000201270 001__ 201270
000201270 005__ 20240625085656.0
000201270 0247_ $$2doi$$a10.1002/cmdc.201000133
000201270 0247_ $$2ISSN$$a1860-7179
000201270 0247_ $$2ISSN$$a1860-7187
000201270 0247_ $$2WOS$$aWOS:000281061300017
000201270 037__ $$aFZJ-2015-03575
000201270 041__ $$aEnglish
000201270 082__ $$a540
000201270 1001_ $$0P:(DE-HGF)0$$aBolognesi, Maria Laura$$b0$$eCorresponding Author
000201270 245__ $$aDiscovery of a Class of Diketopiperazines as Antiprion Compounds
000201270 260__ $$aWeinheim [u.a.]$$bWiley-VCH$$c2010
000201270 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1433835497_26777
000201270 3367_ $$2DataCite$$aOutput Types/Journal article
000201270 3367_ $$00$$2EndNote$$aJournal Article
000201270 3367_ $$2BibTeX$$aARTICLE
000201270 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000201270 3367_ $$2DRIVER$$aarticle
000201270 520__ $$aPrion diseases are fatal neurodegenerative and infectious disorders for which effective pharmacological tools are not yet available. This unmet challenge and the recently proposed interplay between prion diseases and Alzheimer's have led to a more urgent demand for new antiprion agents. Herein, we report the identification of a novel bifunctional diketopiperazine (DKP) derivative 1 d, which exhibits activity in the low micromolar range against prion replication in ScGT1 cells, while showing low cytotoxicity. Supported by properly addressed molecular modeling studies, we hypothesized that a planar conformation is the major determinant for activity in this class of compounds. Moreover, studies aimed at assessing the mechanism-of-action at the molecular level showed that 1 d might interact directly with recombinant prion protein (recPrP) to prevent its conversion to the pathogenic misfolded prion protein (PrPSc)-like form. This investigation suggests that DKP based antiprion compounds can serve as a promising lead scaffold in developing new drugs to combat prion diseases
000201270 536__ $$0G:(DE-HGF)POF2-899$$a899 - ohne Topic (POF2-899)$$cPOF2-899$$fPOF I$$x0
000201270 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000201270 7001_ $$0P:(DE-HGF)0$$aAi Tran, Hoang Ngoc$$b1
000201270 7001_ $$0P:(DE-HGF)0$$aStaderini, Matteo$$b2
000201270 7001_ $$0P:(DE-HGF)0$$aMonaco, Alessandra$$b3
000201270 7001_ $$0P:(DE-HGF)0$$aLópez-Cobeñas, Alberto$$b4
000201270 7001_ $$0P:(DE-HGF)0$$aBongarzone, Salvatore$$b5
000201270 7001_ $$0P:(DE-HGF)0$$aBiarnés, Xevi$$b6
000201270 7001_ $$0P:(DE-HGF)0$$aLópez-Alvarado, Pilar$$b7
000201270 7001_ $$0P:(DE-HGF)0$$aCabezas, Nieves$$b8
000201270 7001_ $$0P:(DE-HGF)0$$aCaramelli, Maria$$b9
000201270 7001_ $$0P:(DE-Juel1)145614$$aCarloni, Paolo$$b10$$ufzj
000201270 7001_ $$0P:(DE-HGF)0$$aMenéndez, J. Carlos$$b11
000201270 7001_ $$0P:(DE-HGF)0$$aLegname, Giuseppe$$b12
000201270 773__ $$0PERI:(DE-600)2209649-8$$a10.1002/cmdc.201000133$$gVol. 5, no. 8, p. 1324 - 1334$$n8$$p1324 - 1334$$tChemMedChem$$v5$$x1860-7179$$y2010
000201270 909CO $$ooai:juser.fz-juelich.de:201270$$pVDB
000201270 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000201270 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000201270 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000201270 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000201270 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000201270 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000201270 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000201270 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000201270 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000201270 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000201270 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF <  5
000201270 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145614$$aForschungszentrum Jülich GmbH$$b10$$kFZJ
000201270 9132_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$aDE-HGF$$bForschungsbereich Materie$$lForschungsbereich Materie$$vohne Topic$$x0
000201270 9131_ $$0G:(DE-HGF)POF2-899$$1G:(DE-HGF)POF2-890$$2G:(DE-HGF)POF2-800$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000201270 920__ $$lyes
000201270 9201_ $$0I:(DE-Juel1)GRS-20100316$$kGRS$$lGRS$$x0
000201270 9201_ $$0I:(DE-Juel1)IAS-5-20120330$$kIAS-5$$lComputational Biomedicine$$x1
000201270 980__ $$ajournal
000201270 980__ $$aVDB
000201270 980__ $$aI:(DE-Juel1)GRS-20100316
000201270 980__ $$aI:(DE-Juel1)IAS-5-20120330
000201270 980__ $$aUNRESTRICTED
000201270 981__ $$aI:(DE-Juel1)INM-9-20140121
000201270 981__ $$aI:(DE-Juel1)IAS-5-20120330